An outbreak of enterovirus 71 infection in metropolitan Sydney: Enhanced surveillance and lessons learnt

Medical Journal of Australia

Volumn 201, Issue 11, 2014, Pages 663-666

  Zander, Alexis ^a,b   Britton, Philip N ^c,d   Navin, Tina ^a   Horsley, Emily ^e   Tobin, Sean ^f   McAnulty, Jeremy M ^f  

^a NEW SOUTH WALES MINISTRY OF HEALTH   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

^d CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^e Northern Beaches Health Service   (Australia)

^f Health Protection   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; IMMUNOGLOBULIN;

ARTICLE; AUSTRALIA; CHILD; CLINICAL FEATURE; DISEASE COURSE; DISEASE SEVERITY; DISEASE SURVEILLANCE; ENTEROVIRUS 71; ENTEROVIRUS 71 INFECTION; ENTEROVIRUS INFECTION; EPIDEMIC; FEVER; HAND FOOT AND MOUTH DISEASE; HEALTH SURVEY; HOSPITAL ADMISSION; HUMAN; LENGTH OF STAY; LETHARGY; MAJOR CLINICAL STUDY; MYOCLONUS; NONHUMAN; RASH; CITY; DISEASE OUTBREAKS; EMERGENCY HEALTH SERVICE; ENCEPHALITIS, VIRAL; ENTEROVIRUS; ENTEROVIRUS INFECTIONS; FEMALE; INFANT; MALE; NEWBORN; PRESCHOOL CHILD; STATISTICS AND NUMERICAL DATA; VIROLOGY;

CHILD; CHILD, PRESCHOOL; CITIES; DISEASE OUTBREAKS; EMERGENCY SERVICE, HOSPITAL; ENCEPHALITIS, VIRAL; ENTEROVIRUS A, HUMAN; ENTEROVIRUS INFECTIONS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; NEW SOUTH WALES; POPULATION SURVEILLANCE;

EID: 84924766890     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/mja14.00014     Document Type: Article

References (18)

1. Solomon T, Lewthwaite P, Perera D, et al. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis 2010; 10: 778-790.
2. World Health Organization. Emerging disease surveillance and response. A guide to clinical management and public health response for hand, foot and mouth disease (HFMD). Geneva: WHO, 2011. http://www. wpro. who. int/entity/emerging_diseases/documents/HFMDGuidance/en/index. html (accessed May 2014).
3. Chan LG, Parashar UD, Lye MS, et al. Deaths of children during an outbreak of hand, foot, and mouth disease in Sarawak, Malaysia: clinical and pathological characteristics of the disease. Clin Infect Dis 2000; 31: 678-683.
4. Pérez-Vélez CM, Anderson MS, Robinson CC, et al. Outbreak of neurologic enterovirus type 71 disease: a diagnostic challenge. Clin Infect Dis 2007; 45: 950-957.
5. Gilbert GL, Dickson KE, Waters MJ, et al. Outbreak of enterovirus 71 infection in Victoria, Australia, with a high incidence of neurologic involvement. Pediatr Infect Dis J 1988; 7: 484-488.
6. McMinn P, Stratov I, Nagarajan L, Davis S. Neurological manifestations of enterovirus 71. infection in children during an outbreak of hand, foot, and mouth disease in Western Australia. Clin Infect Dis 2001; 32: 236-242.
7. Nolan MA, Craig ME, Lahra MM, et al. Survival after pulmonary edema due to enterovirus 71 encephalitis. Neurology 2003; 60: 1651-1656.
8. Muscatello DJ, Churches T, Kaldor J, et al. An automated, broad-based, near real-time public health surveillance system using presentations to hospital emergency departments in New South Wales, Australia. BMC Public Health 2005; 5: 141.
9. Ooi MH, Wong SC, Lewthwaite P, et al. Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol 2010; 9: 1097-1105.
10. Ooi MH, Solomon T, Podin Y, et al. Evaluation of diff erent clinical sample types in diagnosis of human enterovirus 71-associated hand-footand-mouth disease. J Clin Microbiol 2007; 45: 1858-1866.
11. Chang LY, Lin TY, Hsu KH, et al. Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease. Lancet 1999; 354: 1682-1686.
12. McMinn PC. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev 2002; 26: 91-107.
13. Ang LW, Koh BK, Chan KP, et al. Epidemiology and control of hand, foot and mouth disease in Singapore, 2001-2007. Ann Acad Med Singapore 2009; 38: 106-112.
14. Sanders SA, Herrero LJ, McPhie K, et al. Molecular epidemiology of enterovirus 71 over two decades in an Australian urban community. Arch Virol 2006; 151: 1003-1013.
15. McMinn P, Lindsay K, Perera D, et al. Phylogenetic analysis of enterovirus 71 strains isolated during linked epidemics in Malaysia, Singapore, and Western Australia. J Virol 2001; 75: 7732-7738.
16. Roberts J, Thorley B. Human enterovirus 71-Australia: sub-genogroup C4A, acute flaccid paralysis. International Society for Infectious Diseases ProMED-mail [Internet] 2013; 26 May. Archive Number: 20130526. 1738087. hhttp://promedmail. chip. org/pipermail/promededr/2013-May/000509. html (accessed Jun 2013).
17. Zhu FC, Meng FY, Li JX, et al. Efficacy, safety, and immunology of an inactivated alumadjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 2013; 381: 2024-2032.
18. Crawford NW, Graham SM. EV71 vaccine: protection from a previously neglected disease. Lancet 2013; 381: 1968-1970.